Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker 
function

Deutschmeyer, Verena; Breuer, Janina; Walesch, Sara K.; Sokol, Anna M.; Graumann, Johannes; Bartkuhn, Marek; Boettger, Thomas; Rossbach, Oliver; Richter, Antje M.

doi:10.1186/s13148-019-0774-2

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function

MPS-Authors

/persons/resource/persons239399

Sokol, Anna M.
Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons228784

Graumann, Johannes
Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons224044

Boettger, Thomas
Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons248833

Richter, Antje M.
Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Deutschmeyer, V., Breuer, J., Walesch, S. K., Sokol, A. M., Graumann, J., Bartkuhn, M., et al. (2019). Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function. CLINICAL EPIGENETICS, 11(1): 182. doi:10.1186/s13148-019-0774-2.

Cite as: https://hdl.handle.net/21.11116/0000-0006-AF11-2

Abstract

There is no abstract available